Structure-Activity Relationship Studies on Novel Antiviral Agents for Norovirus Infections.

SARs antiviral agents computer-aided drug design human norovirus

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
24 Aug 2021
Historique:
received: 23 07 2021
revised: 11 08 2021
accepted: 17 08 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Human norovirus is the leading cause of acute gastroenteritis worldwide, affecting every year 685 million people. Norovirus outbreaks are associated with very significant economic losses, with an estimated societal cost of 60 billion USD per year. Despite this, no therapeutic options or vaccines are currently available to treat or prevent this infection. An antiviral therapy that can be used as treatment and as a prophylactic measure in the case of outbreaks is urgently needed. We previously described the computer-aided design and synthesis of novel small-molecule agents able to inhibit the replication of human norovirus in cell-based systems. These compounds are non-nucleoside inhibitors of the viral polymerase and are characterized by a terminal

Identifiants

pubmed: 34576691
pii: microorganisms9091795
doi: 10.3390/microorganisms9091795
pmc: PMC8468020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Microbiol Rev. 2015 Jan;28(1):134-64
pubmed: 25567225
Chem Soc Rev. 2021 Mar 21;50(6):3647-3655
pubmed: 33524090
Med Res Rev. 2019 May;39(3):860-886
pubmed: 30584800
Viruses. 2019 Feb 20;11(2):
pubmed: 30791582
Medicine (Abingdon). 2017 Nov;45(11):690-694
pubmed: 32288581
Front Immunol. 2020 Jul 07;11:1383
pubmed: 32733458
J Med Chem. 2015 Dec 24;58(24):9438-50
pubmed: 26258852
J Gen Virol. 2019 Oct;100(10):1393-1406
pubmed: 31483239
J Virol. 2013 Nov;87(21):11798-805
pubmed: 23986582
PLoS One. 2016 Apr 26;11(4):e0151219
pubmed: 27115736
Antiviral Res. 2016 Aug;132:46-9
pubmed: 27210811
Sci Rep. 2019 Dec 5;9(1):18413
pubmed: 31804593
Sci Rep. 2018 Mar 7;8(1):4129
pubmed: 29515206
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29530860
Antimicrob Agents Chemother. 2014 Aug;58(8):4675-81
pubmed: 24890597
Adv Food Nutr Res. 2018;86:13-53
pubmed: 30077220

Auteurs

Salvatore Ferla (S)

Medical School, Swansea University, Swansea SA28PP, UK.

Carmine Varricchio (C)

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, UK.

William Knight (W)

Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea SA28PP, UK.

Pui Kei Ho (PK)

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, UK.

Fabiana Saporito (F)

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, UK.

Beatrice Tropea (B)

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, UK.

Giulio Fagan (G)

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, UK.

Ben Matthew Flude (BM)

Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea SA28PP, UK.

Federica Bevilacqua (F)

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, UK.

Nanci Santos-Ferreira (N)

Rega Institute for Medical Research, University of Leuven, 3000 Leuven, Belgium.

Jana Van Dycke (J)

Rega Institute for Medical Research, University of Leuven, 3000 Leuven, Belgium.

Johan Neyts (J)

Rega Institute for Medical Research, University of Leuven, 3000 Leuven, Belgium.

Andrea Brancale (A)

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, UK.

Joana Rocha-Pereira (J)

Rega Institute for Medical Research, University of Leuven, 3000 Leuven, Belgium.

Marcella Bassetto (M)

Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea SA28PP, UK.

Classifications MeSH